Innovative fish peptide-loaded chitosomes: Advancing bioactive delivery through comprehensive in vitro and in vivo assessments

• Study focuses on encapsulating fish peptide into chitosan-stabilized lipid vesicles. • Chitosomes: biocompatible lipid vesicles stabilized by chitosan, encapsulate bioactives. • In vitro , L929 cells show high biocompatibility, efficient uptake, and maintained viability. • In vivo , Albino Wistar rats showed chitosomes were well-tolerated with favorable stability. • Findings support fish peptide-loaded chitosomes for bioactive delivery in diverse fields. Considerable advancements have been achieved in controlled delivery systems, yet ensuring optimal stability, bioavailability, and precise targeting of bioactive compounds continues to present challenges. Addressing this gap, the present study explores chitosomes—lipid vesicles stabilized by chitosan—as a promising approach to enhance the delivery efficiency of bioactive molecules. This study investigate fish peptide-loaded chitosomes, leveraging chitosan's biocompatibility, biodegradability, and encapsulation capabilities. A comprehensive evaluation was conducted under both in vitro and in vivo conditions to assess their potential applications. In vitro studies using L929 cell lines demonstrated high biocompatibility, efficient cellular uptake, and sustained cell viability, with a dose-dependent cytotoxicity profile, leading to early and late apoptosis. The tolerance, favourable metabolic stability, and biomarker responses were validated by in vivo evaluations in Albino Wistar rats, demonstrating systemic efficacy and safety. Moreover, the peptide-chitosome formulation demonstrated a lipid-lowering impact, as evidenced by increases in high-density lipoprotein (HDL) and unsaturated fatty acids and decreases in triglycerides, saturated fatty acid content, and low-density lipoprotein (LDL). These findings highlight the potential of fish peptide-loaded chitosomes as an advanced bioactive delivery system, addressing existing limitations and expanding their applicability in nutraceutical and therapeutic formulations.

Authors

Institutions

Publication Details

Journal
Food Chemistry Advances
Published
2025-03-05
DOI
https://doi.org/10.1016/j.focha.2025.100947
Citations
3
Primary Topic
Protein Hydrolysis and Bioactive Peptides
Type
article
Field-Weighted Citation Impact
2.42

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Innovative fish peptide-loaded chitosomes: Advancing bioactive delivery through comprehensive in vitro and in vivo assessments

Pavan Kumar Dara, Preethy Treesa Paul, Rosemol Jacob M, Suseela Mathew et al.
3 citations
Food Chemistry Advances
Protein Hydrolysis and Bioactive Peptides
2.42
article

Innovative fish peptide-loaded chitosomes: Advancing bioactive delivery through comprehensive in vitro and in vivo assessments

Pavan Kumar Dara, Preethy Treesa Paul, Rosemol Jacob M, Suseela Mathew, P. Amruth, Jean Mary Joy
article en
3 citations

Abstract

• Study focuses on encapsulating fish peptide into chitosan-stabilized lipid vesicles. • Chitosomes: biocompatible lipid vesicles stabilized by chitosan, encapsulate bioactives. • In vitro , L929 cells show high biocompatibility, efficient uptake, and maintained viability. • In vivo , Albino Wistar rats showed chitosomes were well-tolerated with favorable stability. • Findings support fish peptide-loaded chitosomes for bioactive delivery in diverse fields. Considerable advancements have been achieved in controlled delivery systems, yet ensuring optimal stability, bioavailability, and precise targeting of bioactive compounds continues to present challenges. Addressing this gap, the present study explores chitosomes—lipid vesicles stabilized by chitosan—as a promising approach to enhance the delivery efficiency of bioactive molecules. This study investigate fish peptide-loaded chitosomes, leveraging chitosan's biocompatibility, biodegradability, and encapsulation capabilities. A comprehensive evaluation was conducted under both in vitro and in vivo conditions to assess their potential applications. In vitro studies using L929 cell lines demonstrated high biocompatibility, efficient cellular uptake, and sustained cell viability, with a dose-dependent cytotoxicity profile, leading to early and late apoptosis. The tolerance, favourable metabolic stability, and biomarker responses were validated by in vivo evaluations in Albino Wistar rats, demonstrating systemic efficacy and safety. Moreover, the peptide-chitosome formulation demonstrated a lipid-lowering impact, as evidenced by increases in high-density lipoprotein (HDL) and unsaturated fatty acids and decreases in triglycerides, saturated fatty acid content, and low-density lipoprotein (LDL). These findings highlight the potential of fish peptide-loaded chitosomes as an advanced bioactive delivery system, addressing existing limitations and expanding their applicability in nutraceutical and therapeutic formulations.

Food Chemistry AdvancesVol. 7
Central Institute of Fisheries Technology (IN), SRM Institute of Science and Technology (IN), Cochin University of Science and Technology (IN)
Kerala State Council for Science, Technology and Environment
Openalex Percentile: Top 13%
Protein Hydrolysis and Bioactive Peptides
2.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.